Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
/
Financials
Spyre Therapeutics, Inc.
SYRE
Nasdaq Stock Market
SYRE
Nasdaq Stock Market
SYRE
Nasdaq Stock Market
SYRE
Nasdaq Stock Market
Market closed
Market closed
22.46
USD
R
−1.56
−6.49%
At close at Jan 10, 21:20 UTC
USD
No trades
See on Supercharts
Overview
Financials
News
Discussions
Technicals
Forecast
Seasonals
SYRE fundamentals
Overview
Statements
Statistics
Dividends
Earnings
Revenue
More
Spyre Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The annual and quarterly earnings report below will help you understand the performance of SYRE.
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−220.00 M
−110.00 M
0.00
110.00 M
220.00 M
Total revenue
Gross profit
Operating income
Pretax income
Net income
Income statement
Balance sheet
Cash flow
Annual
Annual
Quarterly
Quarterly
More
More
Currency: USD
Q4 '16
Dec 2016
Q1 '17
Mar 2017
Q2 '17
Jun 2017
Q3 '17
Sep 2017
Q4 '17
Dec 2017
Q1 '18
Mar 2018
Q2 '18
Jun 2018
Q3 '18
Sep 2018
Q4 '18
Dec 2018
Q1 '19
Mar 2019
Q2 '19
Jun 2019
Q3 '19
Sep 2019
Q4 '19
Dec 2019
Q1 '20
Mar 2020
Q2 '20
Jun 2020
Q3 '20
Sep 2020
Q4 '20
Dec 2020
Q1 '21
Mar 2021
Q2 '21
Jun 2021
Q3 '21
Sep 2021
Q4 '21
Dec 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q3 '22
Sep 2022
Q4 '22
Dec 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q4 '23
Dec 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
TTM
Total revenue
YoY growth
168.00 K
−95.39%
198.00 K
−85.46%
688.00 K
+10.08%
0.00
−100.00%
0.00
−100.00%
0.00
−100.00%
0.00
−100.00%
0.00
—
—
Cost of goods sold
−490.00 K
−548.00 K
−416.00 K
0.00
0.00
0.00
0.00
0.00
—
Gross profit
YoY growth
−322.00 K
−110.25%
−350.00 K
−140.46%
272.00 K
+81.33%
0.00
+100.00%
0.00
+100.00%
0.00
+100.00%
0.00
−100.00%
0.00
—
—
Operating expenses (excl. COGS)
−18.84 M
−18.46 M
−29.03 M
−33.24 M
−47.75 M
−47.77 M
−44.15 M
−55.39 M
−195.07 M
Operating income
YoY growth
−19.16 M
+6.26%
−18.81 M
+23.06%
−28.76 M
−28.26%
−33.24 M
−77.25%
−47.75 M
−149.21%
−47.77 M
−154.04%
−44.15 M
−53.50%
−55.39 M
−66.62%
−195.07 M
Non-operating income, total
378.00 K
348.00 K
−188.31 M
−6.86 M
−15.43 M
3.95 M
5.31 M
−13.62 M
−19.79 M
Pretax income
YoY growth
−18.78 M
+8.03%
−18.46 M
+24.46%
−217.07 M
−872.82%
−40.10 M
−117.45%
−63.18 M
−236.35%
−43.83 M
−137.43%
−38.84 M
+82.11%
−69.01 M
−72.08%
−214.85 M
Equity in earnings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Taxes
−38.00 K
36.00 K
−7.00 K
−3.00 K
0.00
−32.00 K
0.00
−18.00 K
−50.00 K
Non-controlling/minority interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
After tax other income/expense
0.00
0.00
0.00
0.00
243.91 M
17.45 M
12.08 M
15.31 M
288.76 M
Net income before discontinued operations
−18.82 M
−18.42 M
−217.08 M
−40.11 M
180.73 M
−26.41 M
−26.75 M
−53.71 M
73.86 M
Discontinued operations
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Net income
YoY growth
−18.82 M
+7.94%
−18.42 M
+24.61%
−217.08 M
−872.45%
−40.11 M
−119.96%
180.73 M
—
−26.41 M
−43.33%
−26.75 M
+87.68%
−53.71 M
−33.93%
73.86 M
Dilution adjustment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
Preferred dividends
0.00
0.00
0.00
0.00
—
—
—
—
—
Diluted net income available to common stockholders
−18.82 M
−18.42 M
−217.08 M
−40.11 M
180.73 M
−26.41 M
−26.75 M
−53.71 M
73.86 M
Basic earnings per share (Basic EPS)
YoY growth
−7.20
+30.47%
−4.89
+47.22%
−56.79
−736.54%
−9.34
−93.02%
11.58
—
−0.72
+85.20%
−0.59
+98.96%
−1.06
+88.70%
9.21
Diluted earnings per share (Diluted EPS)
YoY growth
−7.20
+30.47%
−4.89
+47.22%
−56.79
−736.54%
−9.34
−93.02%
11.58
—
−0.72
+85.20%
−0.59
+98.96%
−1.06
+88.70%
9.21
Average basic shares outstanding
2.61 M
3.77 M
3.82 M
4.29 M
15.61 M
36.51 M
45.32 M
50.89 M
—
Diluted shares outstanding
2.61 M
3.77 M
3.82 M
4.29 M
15.61 M
36.51 M
45.32 M
50.89 M
—
EBITDA
YoY growth
−18.67 M
+6.36%
−18.26 M
+23.75%
−28.34 M
−29.14%
−33.24 M
−82.13%
−47.75 M
−155.75%
−47.77 M
−161.66%
−44.15 M
−55.75%
−55.39 M
−66.62%
−195.07 M
EBIT
YoY growth
−19.16 M
+6.26%
−18.81 M
+23.06%
−28.76 M
−28.26%
−33.24 M
−77.25%
−47.75 M
−149.21%
−47.77 M
−154.04%
−44.15 M
−53.50%
−55.39 M
−66.62%
−195.07 M
Total operating expenses
−19.33 M
−19.00 M
−29.45 M
−33.24 M
−47.75 M
−47.77 M
−44.15 M
−55.39 M
−195.07 M